-
ALISADE 27.5 micrograms/spray nasal spray suspension
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: R01AD12
-
alli 27 mg chewable tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: A08AB01
- Active Substance: Orlistat
-
alli 60 mg hard capsules
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: A08AB01
- Active Substance: Orlistat
-
Altargo 1% ointment
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: D06AX13
-
Atriance 5 mg/ml solution for infusion
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: L01BB07
-
AVAMYS 27.5 micrograms/spray nasal spray suspension
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: R01AD12
-
INTEGRILIN 0.75 mg/ml solution for infusion
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: B01AC16
- Active Substance: Eptifibatide
-
INTEGRILIN 2 mg/ml solution for injection
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: B01AC16
- Active Substance: Eptifibatide
-
Treatment initiation packTrobalt 50 mg film-coated tabletsTrobalt 100 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Trobalt 100 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Trobalt 200 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Trobalt 300 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Trobalt 400 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Trobalt 50 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: N03AX21
- Therapeutic Area: Epilepsy
-
Tyverb 250 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: L01XE07
-
Volibris 10 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: C02KX02
- Therapeutic Area: Hypertension
-
Volibris 5 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: C02KX02
- Therapeutic Area: Hypertension
-
Votrient 200 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: L01XE11
- Active Substance: Hydrochloride
-
Votrient 400 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: L01XE11
- Active Substance: Hydrochloride
-
Zeffix 100 mg film-coated tablets
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: J05AF05
- Therapeutic Area: Hepatitis B
- Active Substance: Lamivudine
-
Zeffix 5 mg/ml oral solution
- admission: Great Britain
- Producer: Glaxo Group Ltd.
- ATC-Code: J05AF05
- Therapeutic Area: Hepatitis B
- Active Substance: Lamivudine